| Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution S López, EL Lim, S Horswell, K Haase, A Huebner, M Dietzen, ... Nature genetics 52 (3), 283-293, 2020 | 195 | 2020 |
| Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ... Cancer Cell 39 (11), 1497-1518. e11, 2021 | 150 | 2021 |
| The evolution of lung cancer and impact of subclonal selection in TRACERx AM Frankell, M Dietzen, M Al Bakir, EL Lim, T Karasaki, S Ward, ... Nature 616 (7957), 525-533, 2023 | 81 | 2023 |
| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 77 | 2023 |
| Representative sequencing: unbiased sampling of solid tumor tissue K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ... Cell reports 31 (5), 2020 | 59 | 2020 |
| Abstract CT023: Phylogenetic tracking and minimal residual disease detection using ctDNA in early-stage NSCLC: A lung TRACERx study C Abbosh, A Frankell, A Garnett, T Harrison, M Weichert, A Licon, ... Cancer Research 80 (16_Supplement), CT023-CT023, 2020 | 56 | 2020 |
| The evolution of non-small cell lung cancer metastases in TRACERx M Al Bakir, A Huebner, C Martínez-Ruiz, K Grigoriadis, TBK Watkins, ... Nature 616 (7957), 534-542, 2023 | 55 | 2023 |
| Genomic–transcriptomic evolution in lung cancer and metastasis C Martínez-Ruiz, JRM Black, C Puttick, MS Hill, J Demeulemeester, ... Nature 616 (7957), 543-552, 2023 | 46 | 2023 |
| Evolutionary characterization of lung adenocarcinoma morphology in TRACERx T Karasaki, DA Moore, S Veeriah, C Naceur-Lombardelli, A Toncheva, ... Nature medicine 29 (4), 833-845, 2023 | 32 | 2023 |
| Body composition and lung cancer-associated cachexia in TRACERx O Al-Sawaf, J Weiss, M Skrzypski, JM Lam, T Karasaki, F Zambrana, ... Nature medicine 29 (4), 846-858, 2023 | 18 | 2023 |
| An economical, quantitative, and robust protocol for high-throughput T cell receptor sequencing from tumor or blood I Uddin, K Joshi, T Oakes, JM Heather, C Swanton, TRACERx consortium, ... Cancer Immunosurveillance: Methods and Protocols, 15-42, 2019 | 17 | 2019 |
| Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ... Cancer Discovery 13 (6), 1364-1385, 2023 | 16 | 2023 |
| CONIPHER: a computational framework for scalable phylogenetic reconstruction with error correction K Grigoriadis, A Huebner, A Bunkum, E Colliver, AM Frankell, MS Hill, ... Nature Protocols 19 (1), 159-183, 2024 | 7 | 2024 |
| Whole genome doubling mitigates muller’s ratchet in cancer evolution S López, E Lim, A Huebner, M Dietzen, T Mourikis, TBK Watkins, ... bioRxiv, 513457, 2019 | 7 | 2019 |
| The independent loss model with ordered insertions for the evolution of CRISPR spacers F Baumdicker, AMI Huebner, P Pfaffelhuber Theoretical population biology 119, 72-82, 2018 | 4 | 2018 |
| ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA A Huebner, JRM Black, F Sarno, R Pazo, I Juez, L Medina, ... Genome Medicine 15 (1), 27, 2023 | 3 | 2023 |
| Genomic evolution of non-small cell lung cancer patient-derived xenograft models RE Hynds, A Huebner, DR Pearce, AU Akarca, DA Moore, S Ward, ... bioRxiv, 2023.01. 06.521078, 2023 | 3 | 2023 |
| SnapShot: Tumor evolution A Huebner, M Dietzen, N McGranahan Cell 184 (6), 1650-1650. e1, 2021 | 3 | 2021 |
| Defining the lethal subclone in metastatic lung cancer M Jamal-Hanjani, A Huebner, N McGranahan, C Swanton Annals of Oncology 29, viii702, 2018 | 3 | 2018 |
| Blood culture sampling rate in hospitalised children as a quality indicator for diagnostic stewardship AR Araujo da Silva, E Jaszkowski, T Schober, U von Both, ... Infection 48, 569-575, 2020 | 2 | 2020 |
